A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Latest Alzheimer's antibody is 'not a miracle drug'. | LitMetric

AI Article Synopsis

  • Eli Lilly's donanemab shows potential benefits for Alzheimer's treatment, but the study reveals significant risks that need careful consideration.* -
  • The results indicate that while some patients may experience cognitive improvements, the side effects and overall safety profile raise concerns.* -
  • The findings underline the importance of weighing therapeutic benefits against adverse effects when evaluating donanemab for broader use in patients.*

Article Abstract

Results on Eli Lilly's donanemab highlight stark risk-benefit trade-offs.

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.adi6515DOI Listing

Publication Analysis

Top Keywords

latest alzheimer's
4
alzheimer's antibody
4
antibody 'not
4
'not miracle
4
miracle drug'
4
drug' eli
4
eli lilly's
4
lilly's donanemab
4
donanemab highlight
4
highlight stark
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!